Home » pressreleases » Bridging Studies

Centre for Human Drug Research - Early Phase Drug Development

Press
Release

Bridging Studies

The Japan Clinical Pharmacology Network for Global Trials (J-CLIPNET) is a network consisting of six of the most prestigeous Japanese university hospitals and clinical trial centres in Korea, China and the Netherlands, all with extensive experience in human pharmacology and clinical trials.

Within the J-CLIPNET consortium, CHDR has performed highly efficient bridging studies using the same protocol in both countries simultaneously. Several Japanese pharmacologists also received their training at CHDR.

For this occasion Prof Dr Kyoichi Ohashi, J-CLIPNET representative, and our CEO Prof Dr Adam Cohen have signed a ceremonial letter of understanding which emphasises the commitment of both organisations and the contribution of mutual research and education. This collaboration offers yet another unique opportunity for our clients to combine top-level science and excellent operational activities in a full service model, this time allowing to build the difficult bridges between trials in US/Europe and Asia.

Please contact our business development office who will be delighted to arrange a meeting in any of the J CLIPNET countries.

Contact Centre for Human Drug Research - Early Phase Drug Development

Centre for Human Drug Research - Early Phase Drug Development

Early Phase Drug Development